Allergan, which is fending off a $53 billion takeover bid by Valeant, released emails sent by senior Morgan Stanley bankers appearing to denigrate Valeant and its business strategy.
from WSJ.com: US Business http://ift.tt/1lL002L
via IFTTT
from WSJ.com: US Business http://ift.tt/1lL002L
via IFTTT
No comments:
Post a Comment